There is currently no cure for Parkinson's Disease. But some with Parkinson's are finding that an unusual therapy – rock ...

AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...

AC Immune SA (ACIU) has released an update. AC Immune SA announced promising interim results from its Phase 2 trial of the ACI-7104.056 ...

The Lafayette Area Parkinson's Support, known as LeAPS, is a new nonprofit that will be offered to those impacted by ...

Parkinson’s disease is a movement disorder of the nervous system that ... That can include regular exercise and speech ...

Sepah clearly stated that the concept was based on cognitive behavioral therapy (CBT), an evidence-based technique ...

The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.

Armed with data from a small phase 1/2 bridging study, MeiraGTx is preparing to take its gene therapy for Parkinson's disease into a pivotal trial. Shares in the Anglo-US biotech rose sharply ...

THOSE afflicted with Parkinson’s disease (PD) must contend with tremors, stiffness, and uncontrollable movements in their body as a result of the deterioration of their nervous system. Proper care is ...

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.